The global cell culture products market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biopharmaceuticals and tissue engineering products. The biopharmaceutical manufacturing segment accounted for the largest share in the global cell culture products market in 2018, followed by tissue engineering and gene therapy segments.
The classical media & salts segment accounted for the largest share in the global cell culture products market in 2018, followed by serufree media and stem cell media segments. Biopharmaceutical manufacturing was estimated to account for a major share of this market owing to its high demand from pharmaceutical companies across various regions such as North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) and others.
Some Of The Growth Factors Of This Market:
- The Cell Culture Products market is driven by the increasing demand for biopharmaceuticals and vaccines, which are used in the treatment of cancer, diabetes, and other diseases.
- Increasing research and development activities in the field of biotechnology will drive the growth of this market.
- Increasing awareness about stem cell therapy will also drive this market.
- Increasing government funding for research on stem cells will also fuel this market.
Industry Growth Insights published a new data on “Cell Culture Products Market”. The research report is titled “Cell Culture Products Market research by Types (Classical Media & Salts, Serum-free Media, Stem Cell Media), By Applications (Biopharmaceutical Manufacturing, Tissue Culture & Engineering, Gene Therapy, Cytogenetic), By Players/Companies Life Technologies, Corning (Cellgro), Sigma-Aldrich, Thermo Fisher, Merck Millipore, GE Healthcare, Lonza, BD, HiMedia, Takara, CellGenix, Atlanta Biologicals, PromoCell, Zenbio”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Culture Products Market Research Report
By Type
Classical Media & Salts, Serum-free Media, Stem Cell Media
By Application
Biopharmaceutical Manufacturing, Tissue Culture & Engineering, Gene Therapy, Cytogenetic
By Companies
Life Technologies, Corning (Cellgro), Sigma-Aldrich, Thermo Fisher, Merck Millipore, GE Healthcare, Lonza, BD, HiMedia, Takara, CellGenix, Atlanta Biologicals, PromoCell, Zenbio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Cell Culture Products Market Report Segments:
The global Cell Culture Products market is segmented on the basis of:
Types
Classical Media & Salts, Serum-free Media, Stem Cell Media
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Manufacturing, Tissue Culture & Engineering, Gene Therapy, Cytogenetic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Life Technologies
- Corning (Cellgro)
- Sigma-Aldrich
- Thermo Fisher
- Merck Millipore
- GE Healthcare
- Lonza
- BD
- HiMedia
- Takara
- CellGenix
- Atlanta Biologicals
- PromoCell
- Zenbio
Highlights of The Cell Culture Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Classical Media & Salts
- Serum-free Media
- Stem Cell Media
- By Application:
- Biopharmaceutical Manufacturing
- Tissue Culture & Engineering
- Gene Therapy
- Cytogenetic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Culture Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell culture products are materials and devices used to maintain cells in the laboratory. These products can include media, incubators, and other equipment.
Some of the major players in the cell culture products market are Life Technologies, Corning (Cellgro), Sigma-Aldrich, Thermo Fisher, Merck Millipore, GE Healthcare, Lonza, BD, HiMedia, Takara, CellGenix, Atlanta Biologicals, PromoCell, Zenbio.
The cell culture products market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell Culture Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell Culture Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell Culture Products Market - Supply Chain
4.5. Global Cell Culture Products Market Forecast
4.5.1. Cell Culture Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell Culture Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cell Culture Products Market Absolute $ Opportunity
5. Global Cell Culture Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cell Culture Products Market Size and Volume Forecast by Type
5.3.1. Classical Media & Salts
5.3.2. Serum-free Media
5.3.3. Stem Cell Media
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cell Culture Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cell Culture Products Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Manufacturing
6.3.2. Tissue Culture & Engineering
6.3.3. Gene Therapy
6.3.4. Cytogenetic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cell Culture Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cell Culture Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cell Culture Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cell Culture Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cell Culture Products Demand Share Forecast, 2019-2029
9. North America Cell Culture Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cell Culture Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cell Culture Products Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Manufacturing
9.4.2. Tissue Culture & Engineering
9.4.3. Gene Therapy
9.4.4. Cytogenetic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cell Culture Products Market Size and Volume Forecast by Type
9.7.1. Classical Media & Salts
9.7.2. Serum-free Media
9.7.3. Stem Cell Media
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cell Culture Products Demand Share Forecast, 2019-2029
10. Latin America Cell Culture Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cell Culture Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cell Culture Products Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Manufacturing
10.4.2. Tissue Culture & Engineering
10.4.3. Gene Therapy
10.4.4. Cytogenetic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cell Culture Products Market Size and Volume Forecast by Type
10.7.1. Classical Media & Salts
10.7.2. Serum-free Media
10.7.3. Stem Cell Media
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cell Culture Products Demand Share Forecast, 2019-2029
11. Europe Cell Culture Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cell Culture Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cell Culture Products Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Manufacturing
11.4.2. Tissue Culture & Engineering
11.4.3. Gene Therapy
11.4.4. Cytogenetic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cell Culture Products Market Size and Volume Forecast by Type
11.7.1. Classical Media & Salts
11.7.2. Serum-free Media
11.7.3. Stem ell Media
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cell Culture Products Demand Share, 2019-2029
12. Asia Pacific Cell Culture Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cell Culture Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cell Culture Products Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Manufacturing
12.4.2. Tissue Culture & Engineering
12.4.3. Gene Therapy
12.4.4. Cytogenetic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cell Culture Products Market Size and Volume Forecast by Type
12.7.1. Classical Media & Salts
12.7.2. Serum-free Media
12.7.3. Stem Cell Media
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cell Culture Products Demand Share, 2019-2029
13. Middle East & Africa Cell Culture Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cell Culture Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cell Culture Products Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Manufacturing
13.4.2. Tissue Culture & Engineering
13.4.3. Gene Therapy
13.4.4. Cytogenetic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cell Culture Products Market Size and Volume Forecast by Type
13.7.1. Classical Media & Salts
13.7.2. Serum-free Media
13.7.3. Stem Cell Media
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cell Culture Products Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Cell Culture Products Market: Market Share Analysis
14.2. Cell Culture Products Distributors and Customers
14.3. Cell Culture Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Life Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Corning (Cellgro)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigma-Aldrich
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck Millipore
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GE Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lonza
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BD
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. HiMedia
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Takara
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CellGenix
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Atlanta Biologicals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PromoCell
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Zenbio
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
